National Cancer Institute; Notice of Closed Meetings, 76669 [E8-29824]
Download as PDF
Federal Register / Vol. 73, No. 243 / Wednesday, December 17, 2008 / Notices
pwalker on PROD1PC71 with NOTICES
Name of Committee: National Cancer
Institute Special Emphasis Panel; Clinical
Studies P01.
Date: February 18, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Majed M. Hamawy, PhD,
Scientific Review Officer, Research Programs
Review Branch, Division Of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8135,
Bethesda, MD 20852, 301–594–5659,
mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Quantitative Imaging for Evaluation of
Responses to Cancer Therapies.
Date: March 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC North
Gaithersburg, 620 Perry Parkway,
Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI Cancer
Prevention Research.
Date: March 16–17, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Luxury Hotel and Suites,
2033 M Street, NW., Washington, DC 20036.
Contact Person: Irina Gordienko, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm. 7073, Bethesda,
MD 20892, 301–594–1566,
gordienkoiv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29822 Filed 12–16–08; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
18:58 Dec 16, 2008
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I—Career Development.
Date: February 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Washington DC,
1515 Rhode Island Ave, Washington, DC
20005.
Contact Person: Sonya Roberson, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8109, Bethesda, MD 20892, 301–594–1182,
robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Molecular
Profiles in Tumors.
Date: February 19, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Strategies to Protect Radiosensitive Organs.
Date: February 26, 2009.
Time: 9:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marvin L Salin, PhD,
Scientific Review Officer, Special Review
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
76669
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Technologies for Molecular Analysis of
Cancer (R21).
Date: March 4–5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Adriana Stoica, PhD,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd, Ste 703, Room 7072,
Bethesda, MD 20892–8329, 301–594–1408,
Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Platforms
for Improved Diagnosis of Cancer.
Date: March 16–17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington DC North/
Gaithersburg, 620 Perry Parkway,
Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892–8329, 301–496–7576,
bielatk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29824 Filed 12–16–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public as indicated below, with
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 73, Number 243 (Wednesday, December 17, 2008)]
[Notices]
[Page 76669]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29824]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee I--Career Development.
Date: February 10-11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Washington DC, 1515 Rhode Island Ave,
Washington, DC 20005.
Contact Person: Sonya Roberson, PhD, Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8109, Bethesda, MD 20892, 301-594-1182, robersos@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Molecular Profiles in Tumors.
Date: February 19, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Kenneth L. Bielat, PhD, Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7147, Bethesda, MD 20892-8329, 301-496-7576,
bielatk@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Strategies to Protect Radiosensitive Organs.
Date: February 26, 2009.
Time: 9:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Marvin L Salin, PhD, Scientific Review Officer,
Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Technologies for Molecular Analysis of Cancer
(R21).
Date: March 4-5, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Adriana Stoica, PhD, Scientific Review Officer,
Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Ste
703, Room 7072, Bethesda, MD 20892-8329, 301-594-1408,
Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Platforms for Improved Diagnosis of Cancer.
Date: March 16-17, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington DC North/Gaithersburg, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Kenneth L. Bielat, PhD, Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7147, Bethesda, MD 20892-8329, 301-496-7576,
bielatk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-29824 Filed 12-16-08; 8:45 am]
BILLING CODE 4140-01-P